Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer
Loss of vimentin in preoperative biopsies serves as an independent predictor of poor prognosis and lymph node metastases. Incorporating vimentin as a clinical marker can improve risk stratification and treatment decisions.
Authors
- Hilde E. Lien (ORCID: https://orcid.org/0000-0001-7814-9786)
- Frédéric Amant (ORCID: https://orcid.org/0000-0002-5452-4905)
- Kathrine Woie
- Camilla Krakstad (ORCID: https://orcid.org/0000-0002-0174-8139)
- Jone Trovik
- Ingfrid S. Haldorsen (ORCID: https://orcid.org/0000-0001-9313-7564)
- Marta E. Hjelmeland
- Hege F. Berg (ORCID: https://orcid.org/0000-0002-1712-6609)
- Henrica M.J. Werner
Institutions
- Universitair Ziekenhuis Leuven (BE)
- Haukeland University Hospital (NO)
- Maastricht University (NL)
- Maastro Clinic (NL)
- University of Bergen (NO)
- KU Leuven (BE)
Publication Details
- Journal
- BJC Reports
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1038/s44276-024-00105-2
- Citations
- 3
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.75
Funders
- Kreftforeningen
- Helse Vest
- Universitetet i Bergen
- Norges Forskningsråd